Cadrenal Therapeutics, Inc. (CVKD)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Nov 06, 10:15
Cadrenal Therapeutics Price to Book Value : 0.7800 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.7573 |
| November 04, 2026 | 0.8027 |
| November 03, 2026 | 0.8557 |
| November 02, 2026 | 0.7876 |
| October 30, 2026 | 0.7459 |
| October 29, 2026 | 0.7144 |
| October 28, 2026 | 0.7178 |
| October 27, 2026 | 0.7136 |
| October 26, 2026 | 0.6891 |
| October 23, 2026 | 0.727 |
| October 22, 2026 | 0.7346 |
| October 21, 2026 | 0.7724 |
| October 20, 2026 | 0.7876 |
| October 19, 2026 | 0.8027 |
| October 16, 2026 | 0.8254 |
| October 15, 2026 | 0.7346 |
| October 14, 2026 | 0.7724 |
| October 13, 2026 | 0.755 |
| October 12, 2026 | 0.6607 |
| October 09, 2026 | 0.6892 |
| October 08, 2026 | 0.704 |
| October 07, 2026 | 0.7363 |
| October 06, 2026 | 0.7497 |
| October 05, 2026 | 0.7162 |
| October 02, 2026 | 0.712 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.7346 |
| September 30, 2026 | 0.8179 |
| September 29, 2026 | 0.8254 |
| September 28, 2026 | 0.8482 |
| September 25, 2026 | 0.8709 |
| September 24, 2026 | 0.9087 |
| September 23, 2026 | 0.9996 |
| September 22, 2026 | 0.8482 |
| September 21, 2026 | 0.8254 |
| September 18, 2026 | 0.8103 |
| September 17, 2026 | 0.8482 |
| September 16, 2026 | 0.8179 |
| September 15, 2026 | 0.7952 |
| September 14, 2026 | 0.8027 |
| September 11, 2026 | 0.8254 |
| September 10, 2026 | 0.8936 |
| September 09, 2026 | 0.9012 |
| September 08, 2026 | 0.9087 |
| September 04, 2026 | 0.9239 |
| September 03, 2026 | 0.9693 |
| September 02, 2026 | 1.007 |
| September 01, 2026 | 1.144 |
| August 31, 2026 | 1.325 |
| August 28, 2026 | 1.166 |
| August 27, 2026 | 1.185 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 9.660 |
| Veru, Inc. | 1.244 |
| Johnson & Johnson | 8.025 |
| Eli Lilly & Co. | 31.86 |
Price to Book Value Related Metrics
| Price | 1.03 |
| Earnings Yield | -476.0% |
| Market Cap | 3.192M |